Back to search

Characterisation of patients with primary biliary cirrhosis responding to long term ursodeoxycholic acid treatment

Data up to Jan 2025

Published2000
Citations82
References37

Total Citations Per Year

Abstract

References (37)

A simple salting out procedure for extracting DNA from human nucleated cells

1988 • 20,341 citations

Microdroplet Assay of Human Serum Cytotoxins

1964 • 2,088 citations

Prognosis in primary biliary cirrhosis: Model for decision making

1989 • 814 citations

Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)

1978 • 731 citations

Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis

1997 • 624 citations

HL‐A Antigens and Disease Statistical and Genetical Considerations

1974 • 524 citations

Ursodeoxycholic acid in the treatment of primary biliary cirrhosis

1994 • 474 citations

The canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis

1994 • 431 citations

Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis

1985 • 407 citations

Ursodeoxycholic acid in primary biliary cirrhosis: Results of a controlled double-blind trial

1989 • 359 citations

A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis*1

1995 • 275 citations

Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis.

1994 • 242 citations

Measuring the strength of associations between HLA antigens and diseases

1981 • 239 citations

Autoimmune cholangiopathy: Part of the spectrum of autoimmune chronic active hepatitis

1993 • 219 citations

Prevalence of serum antibodies against the p53 tumor suppressor gene protein in various cancers

1994 • 213 citations

Molecular aspects of membrane stabilization by ursodeoxycholate

1993 • 212 citations

Toxicity of bile acids on the electron transport chain of isolated rat liver mitochondria

1994 • 211 citations

Autoimmune cholangitis: A variant of primary biliary cirrhosis

1995 • 178 citations

Bile acid concentrations in human and rat liver tissue and in hepatocyte nuclei

1997 • 177 citations

Tauroursodeoxycholic acid activates protein kinase C in isolated rat hepatocytes

1996 • 141 citations

Rapid HLA‐DRB1 genotyping by nested PCR amplification

1992 • 139 citations

A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis

1995 • 113 citations

Effect of deoxycholic acid and ursodeoxycholic acid on lipid peroxidation in cultured macrophages.

1996 • 112 citations

Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation

1997 • 104 citations

Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis?

1996 • 93 citations

Clinical significance of serum bilirubin levels under ursodeoxycholic acid therapy in patients with primary biliary cirrhosis

1999 • 83 citations

Ursodeoxycholate protects oxidative mitochondrial metabolism from bile acid toxicity: Dose-response study in isolated rat liver mitochondria

1994 • 77 citations

Characterisation of patients with a complete biochemical response to ursodeoxycholic acid.

1995 • 75 citations

Toxicity of bile acids on the electron transport chain of isolated rat liver mitochondria*1

1994 • 71 citations

Effects of ursodeoxycholic acid after 4 to 12 years of therapy in early and late stages of primary biliary cirrhosis

1994 • 48 citations

p53 expression in patients with cirrhosis with and without hepatocellular carcinoma

1995 • 45 citations

Ursodeoxycholate stabilizes phospholipid-rich membranes and mimics the effect of cholesterol: investigations on large unilamellar vesicles

1997 • 42 citations

Antimitochondrial antibody profiles in primary biliary cirrhosis distinguish at early stages between a benign and a progressive course: a prospective study on 200 patients followed for 10 years

1997 • 41 citations

High performance liquid chromatographic determination of free and conjugated bile acids in serum, liver biopsies, bile, gastric juice and feces by fluorescence labeling

1993 • 35 citations

Adjuvant cholylsarcosine during ursodeoxycholic acid treatment of primary biliary cirrhosis.

1998 • 32 citations

Natural course of primary biliary cirrhosis. I. A morphological, clinical and serological analysis of 103 cases

1982 • 31 citations

Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis

1996 • 19 citations

Cited By (0)

Loading...
Characterisation of patients with primary biliary cirrhosis responding to long term… (2000) – Gut | Metascience Observatory Explorer